Published in Medicine and Law Weekly, May 8th, 2009
The Iran Pharmaceuticals and Healthcare Report provides independent forecasts and competitive intelligence on Iran's pharmaceuticals and healthcare industry.
The author is forecasting a 10.2% compound annual growth rate (CAGR) for the Iranian pharmaceutical market, meaning an increase in total value from US$2.25bn in 2008 to US$3.65bn by 2013. We believe the main drivers for growth will include a growing population, a rise in domestic drug...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.